Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2012

May 17, 2012

32870_dirs_2012-05-17_179a92e0-75d0-4ad3-9945-19855423a320.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-05-16

Reporting Person: Intervac, L.L.C. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-16 Common Stock J 191950 Disposed 4527952 Direct

Footnotes

F1: On May 8, 2012, Intervac, L.L.C. redeemed the membership interests of certain of its members (the "Redemption"). The disposition reported on this line occurred as a result of the Redemption. There was no sale of securities by Intervac, L.L.C.